The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan
- PMID: 38265529
- DOI: 10.1007/s10147-023-02457-0
The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan
Abstract
Background: To identify the prognostic impact of treatment centralization in patients with testicular germ cell tumors (TGCT).
Methods: We used a hospital-based cancer registry data in Japan to extract seminoma and non-seminoma cases that were diagnosed in 2013, histologically confirmed, and received the first course of treatment. To compare the 5-years overall survival (OS) rates of patients stratified by institutional care volume, we performed a Cox proportional hazards regression analysis using inverse probability of treatment weighting (IPTW) method to adjust patient backgrounds.
Results: A total of 1767 TGCT patients were identified. The 5-years OS rates for stage II and III TGCT patients treated at low-volume institutions (< 7 cases) were significantly worse than high-volume institutions (≥ 7 cases) (91.2% vs. 83.4%, p = 0.012). Histological stratification revealed that 5-year OS rates for stage II and III seminoma patients in the low-volume group were significantly worse than the high-volume group (93.5% vs. 84.5%, p = 0.041). Multivariate OS analysis using an IPTW-matched cohort showed that institutional care volume was an independent prognostic factor (hazard ratio 2.13 [95% confidence interval: 1.23-3.71], p = 0.0072).
Conclusion: Our results indicate that stage II and III TGCT patients experience lower survival rates at low-volume institutions and would benefit from treatment centralization.
Keywords: Hospital-based cancer registry; Overall survival; Testicular germ cell tumor; Treatment centralization.
© 2024. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.
Similar articles
-
Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.Urology. 2017 May;103:154-160. doi: 10.1016/j.urology.2016.10.018. Epub 2016 Nov 2. Urology. 2017. PMID: 27816603 Free PMC article.
-
Assessment of Prognostic Factors of Racial Disparities in Testicular Germ Cell Tumor Survival in the United States (1992-2015).Biomed Environ Sci. 2021 Feb 20;34(2):152-162. doi: 10.3967/bes2021.021. Biomed Environ Sci. 2021. PMID: 33685574
-
Impact of hospital case volume on testicular cancer outcomes and practice patterns.Urol Oncol. 2018 Jan;36(1):14.e7-14.e15. doi: 10.1016/j.urolonc.2017.08.024. Epub 2017 Sep 19. Urol Oncol. 2018. PMID: 28935185
-
Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich.Acta Oncol. 2005;44(6):529-36. doi: 10.1080/02841860510029923. Acta Oncol. 2005. PMID: 16165911 Review.
-
Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.Curr Opin Urol. 2018 Sep;28(5):448-453. doi: 10.1097/MOU.0000000000000525. Curr Opin Urol. 2018. PMID: 29979237 Review.
Cited by
-
Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan.Int J Clin Oncol. 2024 Nov;29(11):1756-1761. doi: 10.1007/s10147-024-02607-y. Epub 2024 Sep 5. Int J Clin Oncol. 2024. PMID: 39235705
-
The perioperative outcomes of retroperitoneal lymph node dissection in Germany for patients with testicular cancer: Results from the GRAND study.Int J Cancer. 2025 Oct 1;157(7):1333-1341. doi: 10.1002/ijc.35486. Epub 2025 Jun 4. Int J Cancer. 2025. PMID: 40464407 Free PMC article.
References
-
- Purdue MP, Devesa SS, Sigurdson AJ et al (2005) International patterns and trends in testis cancer incidence. Int J Cancer 115(5):822–827. https://doi.org/10.1002/ijc.20931 - DOI - PubMed
-
- Trabert B, Chen J, Devesa SS et al (2015) International patterns and trends in testicular cancer incidence, overall and by histologic subtype. 1973–2007. Andrology 3(1):4–12. https://doi.org/10.1111/andr.293 - DOI - PubMed
-
- Abern MR, Dude AM, Coogan CL et al (2012) Marital status independently predicts testis cancer survival—an analysis of the SEER database. Urol Oncol 30(4):487–493. https://doi.org/10.1016/j.urolonc.2010.03.005 - DOI - PubMed
-
- Williams SB, Ray-Zack MD, Hudgins HK et al (2019) Impact of centralizing care for genitourinary malignancies to high-volume providers: a systematic review. Eur Urol Oncol 2(3):265–273. https://doi.org/10.1016/j.euo.2018.10.006 - DOI - PubMed
-
- Collette L, Sylvester RJ, Stenning SP et al (1999) Impact of the treating institution on survival of patients with “poor-prognosis” metastatic nonseminoma. J Natl Cancer Inst 91(10):839–846. https://doi.org/10.1093/jnci/91.10.839 - DOI - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical